ALUMA Endovascular Systems develops advanced laser energy delivery systems featuring a unique fiber composition integrated into catheters. This technology is intended to deliver highly localized, high-energy laser pulses directly to targeted areas, overcoming the power limitations of existing solutions. The company’s innovation initially addresses a significant unmet medical need affecting millions of patients with chronic disease in small arteries, a condition with limited treatment options and high morbidity and mortality rates. ALUMA was founded in collaboration with Elbit Systems, leveraging combined expertise in laser science and electro-optics, and Shaare Zedek Scientific Ltd. (Mada’it), the research and innovation branch of Shaare Zedek Medical Center in Jerusalem. This partnership blends technological and clinical expertise to serve as the foundation for ongoing innovation.